Get to know the ready-made immunity to protect against ‘RSV virus’ in children in high-risk groups.

Get to know the ready-made immunity to protect against ‘RSV virus’ in children in high-risk groups.

The RSV virus is responsible for more than 60% of acute respiratory infections in children. Recently, AstraZeneca’s RSV ready-made immune system Received approval to register a drug formula in Thailand. For use in prevention among children at high risk. RSV virus It is an important cause of lower respiratory tract infections In children around the … Read more

Preventing the Spread of Respiratory Syncytial Virus (RSV) in the Rainy Season: A Call to Parents and Caregivers

At the end of the rainy season this winter There is a chance of encountering many contagious diseases. One of them is Respiratory Syncytial Virus (RSV). Surveillance data on RSV infection in patients with influenza-like syndrome (ILI) and pneumonia from hospitals in the network. Department of Disease Control in collaboration with the Department of Medical … Read more

FDA Approves New Drug, Beyfortus, to Prevent RSV in Infants and Toddlers

FDA Approves New Drug, Beyfortus, to Prevent RSV in Infants and Toddlers

LOS ANGELES, July 18 (Xinhua) — The U.S. Food and Drug Administration (FDA) on Monday approved a new drug to prevent infants and toddlers from: RSV, or the virus that causes respiratory disease The drug, called Beyfortus, is a monoclonal antibody that is active against RSV. It is approved for use in newborns. and infants … Read more